Alnylam Pharmaceuticals
Rachel Hawley, PharmD, currently serves as the Senior Manager, Health System Medical Outcomes Science Liaison for Alnylam Pharmaceuticals, a role held since July 2023. Alongside this position, Rachel is a Fellow in US Medical Affairs at Northeastern University until October 2024 and also contributes as Adjunct Faculty. Previous experience includes roles as an Inpatient Pharmacy Intern and Technician at SSM Health St. Mary’s Hospital – Madison, and various leadership positions at the University of Wisconsin-Madison School of Pharmacy, including President of the Wisconsin Society of Pharmacy Students (WSPS). Additional internships at Regeneron and experience as a Pharmacy Technician at Ripon Drug Community Pharmacy highlight Rachel's diverse background in the pharmaceutical field. Educational credentials include a Doctor of Pharmacy degree from the University of Wisconsin-Madison School of Pharmacy and a Bachelor of Arts in Chemistry and Biology from Ripon College.
This person is not in any teams
This person is not in any offices
Alnylam Pharmaceuticals
31 followers
Alnylam is the world's leading RNAi therapeutics company and the first and only company to bring an RNAi medicine to market.